Surgeons & Cost¶

The VFS market is split between high-volume laryngology voice centers that have been operating on the larynx for decades and a much smaller field of general otolaryngology and plastic-surgery practices that have begun adopting glottoplasty as demand has grown. Unlike SRS or FFS — where a long tail of cosmetic surgeons compete on price — voice surgery sits inside a small academic ENT subspecialty, and the volume distribution is sharply bimodal. The vocal folds are 10–15 mm long, the technique is unforgiving, and revision options after a poor result are limited; surgeon volume matters more here than in almost any other transfem procedure.

This page covers surgeon selection and cost only. For specific techniques see Wendler's Glottoplasty, Cricothyroid Approximation, Feminization Laryngoplasty, and LAVA & Other Techniques. For who is and isn't a candidate, see Candidacy & Timing. For what to expect after surgery, see Recovery and Complications. For sequencing with facial work, see Combining with FFS overview.

Scope

This page is surgeon selection and cost only. Procedure technique, voice-therapy interaction, and recovery live on the per-procedure pages above. Candidacy, letters, and SLP prerequisites live on Candidacy & Timing.

The two-tier market¶

The market splits cleanly into two tiers, and the distinction matters more than any individual surgeon's marketing or geography.

Tier 1 — high-volume voice centers. Laryngology-fellowship-trained ENT surgeons whose practice is built around the larynx (professional voice users, benign laryngeal disease, microsurgery, framework surgery). VFS fits naturally into this practice. These centers publish cohort outcomes, run integrated speech-language pathology (SLP) services, and offer a structured pre-op / post-op pathway. Examples by published series, not endorsement: Yeson Voice Center (Seoul), UCL Hospital and the Voice Care Centre (London), Hospital Clínic de Barcelona, AZ Sint-Augustinus (Antwerp), Amsterdam UMC, several US academic laryngology programs (UCSF, Boston, Vanderbilt, NYU), and GRS Montréal's affiliated voice service.

Tier 2 — general ENT or plastic-surgery practices that have adopted glottoplasty. Often a single surgeon doing 5–25 VFS cases per year, no published outcome data, no in-house SLP, and a referral pattern that treats VFS as a one-shot cosmetic procedure rather than as the surgical step inside a larger voice-modification plan.

The practical implication: tier matters more than geography or price. A $12K Tier-1 procedure with travel costs added is a safer choice than a $7K Tier-2 glottoplasty by an ENT generalist with no laryngology fellowship and no published series.

What "high-volume voice center" actually means¶

The phrase is used loosely in marketing. A more useful operational definition has five parts; centers that meet all five number in the low dozens worldwide.

Laryngology fellowship. A 1–2 year subspecialty fellowship after ENT residency in laryngeal microsurgery, framework surgery, and professional-voice care. In the US this is recognized by the American Laryngological Association; equivalent fellowship pathways exist at major European academic centers. General ENT residency does not cover the microsurgical techniques used in VFS.
Published outcome series. Peer-reviewed papers reporting acoustic outcomes (fundamental frequency F0, frequency range, jitter/shimmer), patient-reported outcomes (Voice Handicap Index, Trans Woman Voice Questionnaire), and complication rates on the surgeon's own cohort. Series of n≥30 with ≥6-month follow-up is the meaningful threshold; the largest published cohorts (Yeson's glottoplasty series) are in the thousands.
Structured pre-op SLP coordination. A defined relationship with a speech-language pathologist who screens candidates, runs pre-op voice therapy, and confirms that the patient has plateaued on behavioral modification before surgery is offered. Surgeons who operate without pre-op SLP screening are a yellow flag.
Post-op SLP relationship. A defined post-op voice-therapy pathway — typically silence for 1–2 weeks, then graduated voice use guided by an SLP for 2–6 months. The center either employs SLPs in-house or has a published referral relationship for international patients (Yeson's model: a few days of in-person SLP at the center, then a teletherapy hand-off to a home-country SLP).
Revision capacity. Either revises their own complications in-house or has a published referral relationship. VFS revision is much harder than the primary procedure; a surgeon who cannot describe a revision pathway is a yellow flag.

Credentialing: what the letters mean¶

Credential	What it actually means	Useful as a filter?
ENT board certification	Completed ENT residency, passed board exam (ABOto in US; equivalents elsewhere). The minimum surgical credential.	Yes — minimum bar.
Laryngology fellowship	1–2 year subspecialty training after ENT residency in laryngeal microsurgery, framework surgery, professional-voice care.	Yes — the meaningful filter for VFS specifically.
Published peer-reviewed series on own VFS cases	Surgeon has shown their outcomes to other surgeons and survived peer review.	Yes — the strongest single indicator of tier-1 status.
WPATH membership	Paid annual dues. No exam, no audit, no outcome reporting.	Low. Useful for some insurance pathways but not a quality signal.
"Cosmetic surgery" board certification (US)	Not the same as ABMS plastic-surgery board certification. Not relevant for laryngeal surgery.	No. A red flag if presented as the primary credential for VFS.

ENT board certification + laryngology fellowship + a published VFS cohort is a Tier-1 signal. A general-ENT surgeon with no laryngology fellowship and no published series is Tier-2 regardless of marketing.

Yeson Voice Center — the published-technique reference¶

Yeson Voice Center (Seoul, South Korea), founded by Kim Hyung-tae, is the single most frequently cited VFS center in the published literature and in patient communities. It is included here not as an endorsement but because its publication record sets the de facto comparison standard against which other centers are measured.

Protocol. Yeson's full feminization protocol bundles up to four procedures, sequenced or staged depending on the patient:

Glottoplasty (Wendler-derived). The core voice-pitch procedure. Anterior vocal-fold web creation under microlaryngoscopy.
FemLar (Feminization Laryngoplasty). Open-neck framework procedure that physically shortens the thyroid cartilage and re-tensions the folds.
CTA (Cricothyroid Approximation). Sutures the cricoid and thyroid cartilages closer together to tension the folds; effect can fade over 6–12 months in some patients.
Tracheal shave (chondrolaryngoplasty). Cosmetic; reduces the laryngeal prominence.

Published series. Kim Hyung-tae and colleagues have published the largest glottoplasty cohort in the world (cumulative cases reported in the thousands across multiple papers in The Laryngoscope, Journal of Voice, and European Archives of Oto-Rhino-Laryngology). Reported outcomes: mean F0 shift of roughly +60 Hz from baseline (commonly into the 180–220 Hz range from a male baseline of 110–140 Hz), VHI improvement, and a major-complication rate in the low single digits.

Caveats. Yeson's protocol bundles procedures and prices; some patients report pressure to add CTA or FemLar to a glottoplasty package. Critical comparison literature is limited — most independent reviews of Yeson outcomes are written by surgeons who refer patients there.

Surgeons cited via published technique papers¶

The list below cites surgeons by their published technique or outcome papers. This is not an endorsement list. Inclusion means the surgeon has put their work in the peer-reviewed record where it can be evaluated. Omission does not mean a surgeon is bad; it means their work is harder to evaluate from outside.

Surgeon (location)	Technique	Representative published work
Kim Hyung-tae / Yeson Voice Center (Seoul, KR)	Glottoplasty + CTA + FemLar protocol	Kim H-T et al., glottoplasty outcome series in Laryngoscope, J Voice, Eur Arch Otorhinolaryngol; cumulative reported cases in the thousands.
Sandhu, Costello, Karagama and collaborators (UK)	LAVA (Laser-Assisted Voice Adjustment), glottoplasty	UK laryngology series; LAVA technique described in J Laryngol Otol and conference proceedings.
J. Pieter Noordzij, Ramon Franco et al. (US, multiple centers)	Wendler glottoplasty modifications	Technique and outcomes papers in Laryngoscope and J Voice.
Mañas et al. / Hospital Clínic Barcelona (ES)	Wendler's modification (sutured glottoplasty variant)	Mañas et al., outcome series in Spanish and English laryngology literature.
Olivier Nuyens / Sint-Augustinus and affiliated Belgian centers	Glottoplasty cohort series	Nuyens et al., published cohort outcomes; cited in European comparative reviews.
Casado, Rinaldi et al. (Italy)	Glottoplasty outcomes	Italian-cohort outcome papers in J Voice and conference proceedings.
Nawka, Schwarz et al. / Charité Berlin and German centers	Glottoplasty technique modifications	German laryngology literature; technique papers and outcome series.
Mark-Bram Bouman and Amsterdam UMC voice service (NL)	VFS as part of integrated trans-care pathway	Amsterdam UMC long-running gender-surgery program; voice-service outcome papers via the institution's ENT and SLP teams.
Jeffrey Spiegel, Robin Lindsay (Boston, BU/BMC)	Glottoplasty alongside FFS practice	Spiegel et al., glottoplasty technique and outcome papers; integrated with FFS practice.
Mark Courey (Mount Sinai / NYU lineage)	Glottoplasty, professional-voice laryngology	Courey et al., laryngology technique literature; senior US laryngologist publishing on VFS.
C. Gaelyn Garrett (Vanderbilt Voice Center, Nashville)	Glottoplasty, framework surgery	Garrett et al., Vanderbilt voice-center outcome papers.
Pierre Brassard / GRS Montréal voice service (QC)	VFS adjunct to GRS practice	Brassard's center reports VFS as part of a multi-procedure trans-surgery program; published cohort summaries and conference series.

The workflow for any surgeon not on this list is the same: search PubMed for [surgeon last name] glottoplasty or [surgeon last name] voice feminization. A cohort series with n≥30 and ≥6-month acoustic follow-up is tier-1 evidence. Conference abstracts only or technique-description-without-follow-up is a weaker signal.

Regional cost ranges (2026)¶

Ranges are USD-equivalent, surgeon's fee + facility + anesthesia + the SLP component when bundled, not including travel, lodging, or post-op support. VFS is rarely insurance-funded compared to other transfem surgeries, so cash-pay norms dominate.

Region	Procedure	Typical cash price (2026 USD)	Notes
US private (cash)	Wendler glottoplasty	$5,000 – $15,000	Surgeon's fee only at low end; full bundle (facility, anesthesia, SLP visits) at high end.
US private (cash)	FemLar (open framework)	$15,000 – $30,000	Limited US providers; price reflects complexity and OR time.
US private (cash)	CTA	$6,000 – $12,000	Sometimes bundled with glottoplasty.
US insurance	Glottoplasty	Variable; deductible + coinsurance often $2K–$8K out of pocket	Coverage growing but uneven; commonly excluded as "cosmetic" without strong documentation. See below.
Yeson (Seoul, KR)	Glottoplasty	~$8,000 – $9,000	All-inclusive (surgery + on-site SLP days + follow-up). 2026 figure; verify before booking.
Yeson (Seoul, KR)	FemLar	~$10,000 – $12,000	Bundled package; frequently combined with glottoplasty or tracheal shave at incremental cost.
Yeson (Seoul, KR)	Glottoplasty + tracheal shave + CTA package	~$12,000 – $15,000	Plus travel/lodging (typically $2K–$4K for a 1–2 week stay).
UK NHS	Glottoplasty	$0 patient cost	Multi-year wait via Gender Identity Clinic referral; limited surgical providers.
UK private	Glottoplasty	£6,000 – £12,000 (~$7.5K–$15K)	Same surgeons as NHS pathway, faster.
Spain	Glottoplasty	$0 in some autonomous communities; €4,000 – €8,000 private	Regional public coverage variation similar to SRS.
Germany	Glottoplasty	$0 with statutory insurance for documented dysphoria	Wait varies by Land; documentation requirements heavier than US/UK.
Netherlands	Glottoplasty	$0 with basisverzekering	Amsterdam UMC main pathway; multi-year wait.
Belgium	Glottoplasty	€4,000 – €7,000 private	Several published-series surgeons in the Flemish region.
Canada	Glottoplasty	Variable provincial coverage; $0 to ~CAD 8,000 cash	Quebec and Ontario have provincial pathways; coverage of VFS specifically lags coverage of SRS.

The economic comparison most patients run: a Yeson glottoplasty + tracheal shave package at ~$12K–$15K including in-person SLP days, plus travel and lodging (~$2K–$4K for 1–2 weeks), commonly totals less than a full US private FemLar package and is often comparable to or below a US private glottoplasty bundle once SLP add-ons are priced in.

US insurance documentation playbook¶

US insurance coverage of VFS is less mature than coverage of vaginoplasty or FFS. As of 2026, a growing number of large commercial plans and several state Medicaid programs cover glottoplasty when medical necessity is well documented; many plans still default-deny it as "cosmetic" and require appeal. Out-of-pocket cost depends on deductible, coinsurance, and out-of-network status.

Documentation packet — assemble before pre-auth request:

Medical-necessity letter from the prescribing endocrinologist or primary mental-health provider. Should explicitly reference WPATH SOC v8 (2022), note that voice is a recognized component of gender presentation, and state that the patient meets criteria for gender-affirming surgical care.
SLP letter documenting a course of behavioral voice therapy (typically ≥3–6 months) with measured F0 and patient-reported outcomes, and stating that the patient has plateaued on behavioral modification — i.e., that surgery is the next step, not the first step. This is the single most important non-physician document in the packet.
HRT history documenting continuous gender-affirming hormone therapy. Estrogen does not feminize the voice (unlike testosterone, which masculinizes it irreversibly), so HRT history is not technically prerequisite — but most US payers still expect it as part of the broader gender-affirming-care record. See Candidacy & Timing.
Surgeon's letter and CPT codes — typically 31599 (unlisted procedure of larynx) for Wendler glottoplasty, sometimes paired with 31300 (laryngotomy) for open framework surgery. Coding is unsettled and varies by payer; the surgeon's billing office handles this.
Pre-authorization request submitted by the surgeon's office; expect 30–60 days for response.

Appealing denials. "Cosmetic" denials misread WPATH SOC v8, which explicitly addresses voice as a domain of gender expression. Appeal pathway mirrors the SRS pathway:

Internal appeal within the insurer (deadline usually 180 days from denial). Cite SOC v8 and ACA Section 1557.
External review by an independent reviewer (state-regulated; ERISA self-funded plans have their own pathway).
State insurance commissioner complaint for individual and small-group plans.
Lambda Legal, Transgender Law Center, NCTE maintain attorneys who handle high-leverage appeals.

Red flags¶

Patterns associated with worse outcomes or worse patient experience. One is a yellow flag; two or more is a hard pass.

No laryngology fellowship. General ENT or general plastic surgery only. VFS is not a procedure to learn on the job.
No published outcomes. Website features testimonials and audio samples but no peer-reviewed series. F0 shift and complication rate cannot be evaluated.
No SLP coordination, pre- or post-op. Surgeon describes VFS as a one-shot procedure with no behavioral-therapy context. The strongest single red flag.
Operates without pre-op voice therapy. Refusing to require a course of SLP before surgery is a significant outlier from Tier-1 practice.
Specific F0 guarantees. "You will reach 220 Hz." Honest surgeons quote ranges and population data, not individual guarantees.
No revision pathway. "I don't see complications" or "revisions are not needed" — both signal absent follow-up.
Pressure to bundle FemLar or CTA without behavioral-therapy trial. A Tier-1 center steps up from glottoplasty to framework surgery only when glottoplasty has been tried or judged inadequate.
Marketing-heavy, paper-light. Active social media, before/after audio reels, but no PubMed footprint.
Pressure tactics. "Limited slots," deposit demanded at first consultation. Real wait lists at high-volume centers are 6–18 months long.

What to ask in a consultation¶

Did you complete a laryngology fellowship? Where?
How many glottoplasties (and FemLars, CTAs) have you personally performed? In the last 12 months?
What is your published series? Where can I read it?
What is your mean F0 shift, and what is the range across your cohort?
What is your major-complication rate (web breakdown, dysphonia, airway compromise)? See Complications.
What pre-op SLP do you require, and over what timeframe?
What post-op SLP pathway do you have for in-region and out-of-region patients?
If I need a revision, do you do it or refer out? At what cost?
What voice-rest protocol do you use post-op? See Recovery.
Can I speak to former patients at 1 year and 3 years post-op?

For patients combining voice surgery with facial work or bottom surgery, sequencing is its own decision — see Combining with FFS overview and SRS Surgeons & Cost.

Community resources¶

Word-of-mouth ages within 12–24 months and this wiki does not name surgeons as endorsements. Active channels: r/TransVoice and r/Transgender_Surgeries (search surgeon name + "glottoplasty" or "VFS"); TransHealthcare.org surgeon directory (VFS coverage thinner than bottom-surgery coverage); and invite-only trans-care Discord servers with searchable review histories. Cross-reference across at least two channels and confirm a non-trivial published track record before committing to a deposit.

Sources¶

Kim H-T. Glottoplasty for voice feminization in transgender women, cumulative cohort series. Laryngoscope, J Voice, Eur Arch Otorhinolaryngol. PubMed: Kim glottoplasty transgender, Yeson voice feminization.
Wendler J. Original anterior-glottal-web technique description (German laryngology literature, 1990). Foundation for all modern glottoplasty variants.
Mañas et al. / Hospital Clínic Barcelona. Wendler's-modification cohort papers in Spanish/English laryngology literature. PubMed: Mañas glottoplasty.
Nuyens et al. (Belgium). Glottoplasty cohort series, European laryngology literature. PubMed: Nuyens glottoplasty.
Casado JC, Rinaldi V et al. (Italy). Glottoplasty outcome series. PubMed: Casado glottoplasty, Rinaldi voice feminization.
Schwarz, Nawka et al. (Germany). Glottoplasty technique modifications. PubMed: Schwarz glottoplasty, Nawka voice feminization.
Thomas / UK laryngology. LAVA (Laser-Assisted Voice Adjustment) technique description. J Laryngol Otol. PubMed: LAVA voice feminization.
Bouman M-B. and Amsterdam UMC voice service. VFS as part of integrated trans-care pathway. PubMed: Amsterdam transgender voice.
Spiegel J., Lindsay R. Glottoplasty alongside FFS practice. PubMed: Spiegel glottoplasty.
Courey M., Garrett CG. US laryngology technique and cohort papers. PubMed: Courey glottoplasty, Garrett voice feminization.
Brassard P. / GRS Montréal voice service. VFS as adjunct to GRS practice. PubMed and conference series: Brassard voice feminization.
Coleman E. et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Int J Transgender Health 2022;23(S1). WPATH SOC8. Voice and communication chapter is the relevant subsection for medical-necessity letters.
Trans Woman Voice Questionnaire (Dacakis G. et al.) and Voice Handicap Index (Jacobson B. et al.) — patient-reported-outcome instruments standard in VFS publication.
American Board of Otolaryngology (ABOto) and the American Laryngological Association — meaningful US credentials for VFS.
ACA Section 1557 / 45 CFR 92 non-discrimination regulations; HHS Office for Civil Rights guidance (revised multiple times 2016–2026 — verify current version).
Lambda Legal, Transgender Law Center, National Center for Transgender Equality — published insurance-appeal templates and case-law summaries.
Volume-outcome relationship in laryngeal microsurgery: VFS-specific volume-outcome studies are limited but emerging. PubMed: voice feminization volume outcome.